BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11240029)

  • 1. Expression of functional mu-opioid receptors during T cell development.
    McCarthy L; Szabo I; Nitsche JF; Pintar JE; Rogers TJ
    J Neuroimmunol; 2001 Mar; 114(1-2):173-80. PubMed ID: 11240029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.
    Stiene-Martin A; Zhou R; Hauser KF
    Glia; 1998 Mar; 22(3):249-59. PubMed ID: 9482211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of morphine, DPDPE, and U-50488 on apomorphine-induced climbing behavior in mu-opioid receptor knockout mice.
    Jang CG; Lee SY; Park Y; Ma T; Loh HH; Ho IK
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):197-9. PubMed ID: 11597780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of phospholipase C by the cloned mu, delta and kappa opioid receptors via chimeric G alpha(q) mutants.
    Joshi S; Lee JW; Wong YH
    Eur J Neurosci; 1999 Feb; 11(2):383-8. PubMed ID: 10051738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats.
    Kakinohana M; Nakamura S; Fuchigami T; Davison KJ; Marsala M; Sugahara K
    Br J Anaesth; 2006 Jan; 96(1):88-94. PubMed ID: 16317029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feeding responses to mu-, delta- and kappa-opioid receptor agonists in the meat-type chick.
    Bungo T; Kawamura K; Izumi T; Dodo K; Ueda H
    Pharmacol Biochem Behav; 2004 Aug; 78(4):707-10. PubMed ID: 15301925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates.
    Belanger S; Ma W; Chabot JG; Quirion R
    Neuroscience; 2002; 115(2):441-53. PubMed ID: 12421610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
    Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
    Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments.
    Ware TD; Paul D
    Eur J Pharmacol; 2000 Feb; 389(2-3):181-5. PubMed ID: 10688982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of micro, delta or kappa opioid receptors by DAMGO, DPDPE, U-50488 or U-69593 respectively causes antinociception in the formalin test in the naked mole-rat (Heterocephalus glaber).
    Towett PK; Kanui TI; Maloiy GM; Juma F; Olongida Ole Miaron J
    Pharmacol Biochem Behav; 2009 Feb; 91(4):566-72. PubMed ID: 18929596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu and delta opioid receptor regulation of pro-opiomelanocortin peptide secretion from the rat neurointermediate pituitary in vitro.
    Carr JA; Lovering AT
    Neuropeptides; 2000 Feb; 34(1):69-75. PubMed ID: 10688972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of the cloned kappa and mu opioid receptors.
    Tallent M; Dichter MA; Reisine T
    Neuroscience; 1998 Aug; 85(3):873-85. PubMed ID: 9639280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cornea-responsive medullary dorsal horn neurons: modulation by local opioids and projections to thalamus and brain stem.
    Hirata H; Takeshita S; Hu JW; Bereiter DA
    J Neurophysiol; 2000 Aug; 84(2):1050-61. PubMed ID: 10938327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
    Yamamoto A; Sugimoto Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
    Zhang J; Haddad GG; Xia Y
    Brain Res; 2000 Dec; 885(2):143-53. PubMed ID: 11102568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-induced depression in the lamprey respiratory network.
    Mutolo D; Bongianni F; Einum J; Dubuc R; Pantaleo T
    Neuroscience; 2007 Dec; 150(3):720-9. PubMed ID: 17949922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.